Financhill
Back

Viking Therapeutics Stock Predictions

Viking Therapeutics Stock Forecast

  • Over the next 52 weeks, Viking Therapeutics has on average historically risen by 127% based on the past 9 years of stock performance.
  • Viking Therapeutics has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is Viking Therapeutics Stock Undervalued?
    The current Viking Therapeutics [VKTX] share price is $24.99. The Score for VKTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Viking Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Viking Therapeutics has on average historically risen by 127% based on the past 9 years of stock performance.

Viking Therapeutics Stock Rating

Sell
48
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics overpriced?

  • Viking Therapeutics has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

Viking Therapeutics Stock Price History

Is VKTX stock going to rise?

  • The current trend is relatively stagnant and VKTX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vikingtherapeutics.com

52-Week Data

52-Week High:
81.86
52-Week Low:
18.92

Prediction Charts

Market Cap:
2.8B
Price in USD:
24.99
Volume:
4M
Beta:
1.39

Technical Analysis

SMA50:
26.96
SMA100:
33.86
SMA200:
47.24
52-Wk Change:
-63.71%

Stock Predictions

  • Is Viking Therapeutics stock public?
    Yes, Viking Therapeutics is a publicly traded company.
  • What is the Viking Therapeutics stock quote today?
    The Viking Therapeutics stock price is 24.99 USD today.
  • How to buy Viking Therapeutics stock online?
    You can buy Viking Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-7 20.79 21.28 23.00 20.27
Apr-8 22.35 19.98 22.74 19.58
Apr-9 19.63 23.10 23.64 18.92
Apr-10 22.00 21.52 22.49 20.41
Apr-11 21.62 22.22 22.41 21.21
Apr-14 26.95 24.57 27.09 23.57
Apr-15 24.55 23.11 24.64 22.61
Apr-16 22.66 23.60 23.83 22.52
Apr-17 22.04 23.94 24.12 21.23
Apr-21 23.83 23.72 24.68 23.30
Apr-22 24.04 25.48 25.54 24.00
Apr-23 26.09 25.79 26.95 25.70
Apr-24 26.09 25.66 26.85 24.87
Apr-25 25.14 24.99 25.40 24.36

Viking Therapeutics Earnings

Viking Therapeutics Earnings Report: Per Share Viking Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Viking Therapeutics Forecast Revenue Growth

Viking Therapeutics Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.15 per share, a decrease this year of $0.85 per share, and a decrease next year of $0.54 per share.

* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.